By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent and Chungnam National University today announced a collaboration targeting glycomics.

Under the terms of the deal, the partners will develop new applications, methods, technologies, and software tools for glycan analysis. The South Korean university hopes to identify and develop biomarkers for diseases, such as cancer, resulting in the development of therapeutic antibody products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.